PeptideDB

Iristectorin A 37744-61-9

Iristectorin A 37744-61-9

CAS No.: 37744-61-9

Iristectorin A is a naturally occurring compound found in Iris tectorum and has anti-breast cancer activity.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Iristectorin A is a naturally occurring compound found in Iris tectorum and has anti-breast cancer activity.

Physicochemical Properties


Molecular Formula C23H24O12
Molecular Weight 492.4295
Exact Mass 492.126
CAS # 37744-61-9
PubChem CID 11968629
Appearance Off-white to light yellow solid powder
Density 1.6±0.1 g/cm3
Boiling Point 813.6±65.0 °C at 760 mmHg
Flash Point 281.1±27.8 °C
Vapour Pressure 0.0±3.1 mmHg at 25°C
Index of Refraction 1.676
LogP -0.08
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 12
Rotatable Bond Count 6
Heavy Atom Count 35
Complexity 776
Defined Atom Stereocenter Count 5
SMILES

COC1=C(C=C(C=C1)C2=COC3=CC(=C(C(=C3C2=O)O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O

InChi Key HFODKTZIQVSGJO-ZTATXHNCSA-N
InChi Code

InChI=1S/C23H24O12/c1-31-12-4-3-9(5-11(12)25)10-8-33-13-6-14(22(32-2)19(28)16(13)17(10)26)34-23-21(30)20(29)18(27)15(7-24)35-23/h3-6,8,15,18,20-21,23-25,27-30H,7H2,1-2H3/t15-,18-,20+,21-,23-/m1/s1
Chemical Name

5-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro - Proliferative activity on breast cancer cells: Iristectorin A exhibits proliferative activity on two human breast cancer cell lines, MCF-7 and MDA-MB-231. At concentrations of 1 μM, 5 μM, and 10 μM, it significantly increases the cell viability of MCF-7 cells by 12.5%, 28.3%, and 35.7% respectively compared to the control group. For MDA-MB-231 cells, the compound increases cell viability by 10.2%, 24.6%, and 31.4% at the same concentrations. No cytotoxicity is observed at the tested concentrations [1]
Cell Assay - Breast cancer cell proliferation assay: MCF-7 and MDA-MB-231 cells are seeded in 96-well plates at a density of 5×10³ cells per well and incubated overnight to allow attachment. Iristectorin A is dissolved in an appropriate solvent and added to the wells at final concentrations of 1 μM, 5 μM, and 10 μM. The control group receives the same volume of solvent without the compound. Cells are incubated at 37°C in a humidified atmosphere with 5% CO₂ for 72 hours. After incubation, a cell viability assay reagent is added to each well, and the plates are incubated for an additional 4 hours. The absorbance is measured at 490 nm using a microplate reader, and the cell viability rate is calculated relative to the control group [1]
References

[1]. Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines. J Nat Prod. 2005 Mar;68(3):361-4.

Additional Infomation Iristectorin A has been reported in Iris kemaonensis, Iris domestica, and other organisms with data available.
- Iristectorin A is a phenolic constituent isolated from the rhizomes of Belamcanda chinensis, a Thai medicinal plant [1]
- The study focuses on investigating the proliferative activity of phenolic compounds from Belamcanda chinensis, and Iristectorin A is identified as one of the active components with proliferative effects on breast cancer cell lines [1]

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~203.07 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.08 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.08 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0307 mL 10.1537 mL 20.3075 mL
5 mM 0.4061 mL 2.0307 mL 4.0615 mL
10 mM 0.2031 mL 1.0154 mL 2.0307 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.